31 January, 2015

Mebendazole: Another Extraordinary Cure For Cancer


Mebendazole: A Cheap But Effective Cancer Cure Mebendazole or better known as vermox is a deworming medication here in South Africa, used for children and dogs and cats. In the US mebendazole has been completely taken off the shelves, mebendazole cancer remedy is no longer even manufactured since they discovered that this inexpensive deworming medication mainly used by sheep farmers, is a powerful cancer killer. Our body defends itself against cancer cells and are usually destroyed before they can do damage. But for some people with cancer everyday is an ongoing struggle. There is good news. There exists a drug which many magazines have shown that it helps cure cancer. Without side effects. And Big Pharma hopes that you'll never hear about it. It's called mebendazole, in South Africa it is available without a prescription at the pharmacy. If you have kids you might recognize the drug brand names Vermox, Ovex, Antiox or Pripsen. It is usually used against worms. How Does Mebendazole Cancer Remedy Work? An important misconception is that a cell consists only of a nucleus and a cell wall, and that in all the cell (cytoplasm) is moving in a liquid or gel. However, the interior of a cell contains microtubules called spindles. This network of unyielding microtubules gives the cell its shape, structure and ability organelles and different molecules to other areas within the cell to bring about, so they basically act like a train track. The most vital function of these microtubules, cell division. The video below shows how microtubules work and reminds us how complex life is: Mebendazole cancer remedy disrupts the development of spindles so that cell division is prevented. The cell eventually die of old age or apoptosis. Mebendazole is highly selective and falls on the one or other way, only cancer cells (in addition to a whole series of intestinal parasites). The pharmaceutical industry has no interest in mebendazole. Big Pharma promote precisely the more toxic chemotherapy and related drugs because with mebendazole much less profit. What is cancer? It is generally assumed that after cell division produces two identical cells are formed. This is incorrect. DNA is not copied perfectly and usually occur in small errors. When a cell has too many errors in its DNA code, division cannot occur and die off errors in the cell. Over time, keeps the on cell division. With men this is after about 60 divisions. This is also known as the Hayflick limit. Biologists have discovered that are the subject of cancer cells to DNA-damaged cells with a code that the so-called telomer activates, so that the non cell dies. The Hayflick limit is endless. Because of the mutation, the cell is in fact immortal. A cancer cell is different from a healthy cell as it focuses on staying alive longer than normal cells despite it being a dysfunctional cell. Some studies have shown that mebendazole helps cure cancer: The Anthelmintic Drug Mebendazole Induces Apoptosis and mitotic Judgment by depolymerizing tubulin in Non-Small Cell Lung Cancer Cells, Ji-ichiro Sasaki, Rajagopal Ramesh, Sunil Chada, Yoshihito Gomyo, Jack A. Roth and Tapas Mukhopadhyay Molecular Cancer Therapy November 2002 1; 1201 Mebendazole elicits a Potent Antitumor Effect on Human Cancer Cell Lines in Vitro and in Vivo Both, Tapas Mukhopadhyay Ji-ichiro Sasaki, Rajagopal Ramesh, and Jack A. Roth, Clinical Cancer Research September 2002 8; 2963 Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells, Nicole Doudican, Adrianna Rodriguez, Iman Osman and Seth J. Orlow, Molecular Cancer Research, August 2008 6; 1308 Mebendazole Inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice, Daniele Martarelli, Pierluigi Pompei, Caterina Baldi and Giovanni Mazzoni, Cancer Chemotherapy and Pharmacology, volume 61, number 5, 809-817 Mebendazole Monotherapy and Long-Term Disease Control in Metastatic Adrenocortical Carcinoma, Irina Y. Dobrosotskaya, MD, PhD, Gary D. Hammer, MD, David E. Schteingart, MD, Katherine E. fixtures, MD, Francis P. Worden, MD, Endocrine Practice, Volume 17, Number 3 / may-June 2011 Antiparasitic mebendazole shows survival benefit in two preclinical models of glioblastoma multiforme, Ren-Yuan Bai, Verena Staedtke Colette M. Aprhys, Gary L. Gallia and Gregory J. Riggins, Neuro-Oncology (2011) 13 (9): 974-982 Source: Viewzone.com

30 January, 2015

DCA For Cancer Treatment Perfect For Stubborn Cancer


Proof That DCA For Cancer Actually Cures Cancer Sodium dichloroacetate, used with caffeine plus vitb1 as dca cure for cancer. This letter by web editors was received by Dr. Braat MCP, a former pulmonologist, in which he criticized the DCA (dichloroacetate) cancer treatment of the drug. Below is an edited extract followed by comment from Dr. D. Brandsma, a neurologist from the dutch Institute-Antoni van Leeuwenhoek Cancer Hospital in Holland. Why Dichloroacetic acid / DCA For Cancer Treatment? Letter from Braat about DCA Comment by Dr. MCP Braat “The association is set to a negative attitude towards dichloroacetic acid (DCA). DCA anti-cancer effect has not yet been carefully and extensively tested in patients, but there are good arguments for patients who want to try DCA for cancer treatment. I have in my working life, witness many 'miracle cures' , but believe that DCA is a promising agent that potentially could affect the cancer, preferably as adjunctive therapy in addition to standard anti-cancer treatments. For safety sake, DCA for cancer should preferably not be used without medical supervision. At least somebody treating themselves alternatively should inform their doctor that he or she is self-medicating with DCA for cancer, especially as the case of herxing from cancer can be dangerous. The dismissive attitude of oncologists are wrong and provokes self treatment without the regular practitioner been aware that the cancer patient is using dca for cancer, therefore no real medical examination will be undertaken, which is why the patient must inform the doctor as safety protocol. DCA reactivates the mitochondria in cancer cells (Bonnet 2007). In most cancer cells, the mitochondria are disabled, some growth (and metastasis) of cancer promotes while reactivation of the mitochondria by DCA makes cancer cells susceptible to destruction again. DCA's already being used in tablet or drink, especially in children with congenital mitochondrial muscle disease. The numerous clinical studies over the past twenty years have shown that in any case the use of DCA gives little complaints, less than the current anti-cancer treatments. At higher dosage however, patients may sometimes experience a type of nerve stimulation (polyneuropathy), which makes it necessary to stop dosage for a while, medical monitoring is then essential. The group from the University of Alberta, in Edmonton, Alberta (Canada), in 2007 the anti-cancer effect of DCA for cancer as first described, reported in October 2008 that has now started two clinical trials with private sources, in collaboration with the Cross Cancer Institute and the Alberta Cancer Board. Medicor, a Canadian private cancer center, where terminally ill patients who wish to be treated with DCA under medical supervision (but not in the context of mainstream research), in September 2008 describes a 60-70% overall positive response rate in 265 patients with end stage of various forms of cancer, in whom DCA is often used as an adjuvant agent. In summary, DCA is a very promising anti-cancer drug which acts on an important and generally cancer cell mechanism. There is extensive clinical research is needed before it is finally clear whether and which DCA can take place at the regular cancer therapy. It is very understandable and well palpable when those who do not have time, do not want to wait for results of the trials in Alberta. These patients are advised not to use DCA without the knowledge of the medical practitioner; this, therefore, can provide the FDG-PET scan, which is a prerequisite for the treatment; After all, if this is negative, there is no basis for the treatment with DCA.” DCA for cancer treatment works by inactivating lactic acid. All sugar becomes lactic acid in the body which is why sugar is forbidden in the treatment of cancer. If you use dca for cancer you must take homeopathic remedies or adaptogenic herbs that are highly antioxidant, can therefore destroy free radicals and excrete the dead cancer cells and prevent the herx-heimer reaction. Herxing is just the body way of saying the cancer is dead, it can be safely excreted by using turmeric and especially if a cancer patient is been treated with dca for cancer he should be using homeopathic remedies such as turmeric and black pepper combined for anti-oxidant nutrient rich blood. When the cancer dies the body will experience herxing as an allergic reaction to the dead microbes, dead cancer cells and parasites killed by the dca for cancer. How To Treat Herxing While Using DCA For Cancer? Homeopathic remedies such as Turmeric and black pepper combined can also purify the blood and cleanse and regenerate the liver as well. Take 1/4 tsp turmeric with 1/4 fine ground black pepper in half a glass of water twice a day. And if you are using dca for cancer -for every cup of caffeine that you use drink a 250ml water or rooibos tea afterwards as the cancer patient must stay hydrated and caffeine dehydrates the body but it is only used to accelerate the killing of the cancer cells. Other homeopathic remedies such as grapeseed extract, cannabis oil, liposomal vitamin C and carrot and beetroot raw juicing are good to use as supplement when using dca for cancer, but just remember the importance of staying hydrated. This concludes the summary of the letter from Dr. Braat. VtdK asked mrs. dr. D. Brandsma, a neurologist at the Dutch Cancer Institute, for advice. Dr. Brandsma is familiar with the DCA-use in cancer patients, non-regular prescribed by physicians, and has seen serious neurological consequences of this. She has a number of comments on the contribution of Dr. Braat. Watch the video below to understand more about the use of dca for cancer treatment.

09 January, 2015

Cancer Research Uk | Call To Action!


Cancer research uk determined that people who consumed alcohol on a regular basis stand a much higher chance of been diagnosed with cancer than the person who abstains or drinks much less and not in consistent pattern of consuming alcohol. "Alcohol has long been a scientifically established cause of cancer." - Sarah Williams, Cancer Research UK Well, the question I would like to know is, if the cancer research uk team have known that for such a long time, why are the british public so ignorant to the facts regarding consuming booze and cancer? A recent UK cancer research national survey determined that only 47% of british people were fully aware of any direct link between consuming alcohol and cancer diagnosis, or even that alcohol is carcinogenic in nature at all! In a positive light, though, an overwhelming majority of 83 per cent of the people who participated in that poll would vote yes for new and improved nutritional health data labeling of alcoholic beverage produced, for the consumer to become more aware of the risks involving chronic drinking patterns and the dangers thereof. “Alcohol has long been a scientifically established cause of cancer, but there is surprisingly low awareness among the public of this link. -Sarah Williams (Cancer Research Uk) “And it isn't just a risk for heavy drinkers; regularly drinking alcohol puts you at greater risk of seven different types of cancer, including breast and mouth cancer” Concerning cancer research uk stats and more importantly the most reported breast cancer uk diagnosis we should feel the need more than ever to actively promote the prevention of cancer for all british people and even internationally. •49,936 women and 349 men in the UK were diagnosed with invasive breast cancer in 2011. • In 2012 the number of 11,643 reports of female and 73 male deaths from invasive breast cancer were reported in the UK alone. • For those people diagnosed in 2010-2011 in England and Wales are predicted to survive ten or more years, 78% are adult female invasive breast cancer patients, that is under 80% breast cancer survivors in Uk. •breast cancer in both male and female patients...In 2010, a shocking high number of 5,765 women and 26 men in the UK were diagnosed with “in situ breast carcinoma” •27% of annual breast cancer cases in the UK are directly linked to poor lifestyle and other risk factors, which makes cancer prevention and particularly breast cancer prevention a cause worthy of fighting for.   In the EU it isn't a legal prerogative for food and soft drink products to declare nutritional value info, despite the fact that alcohol is classed as a group 1 carcinogen by the WHO. When, if ever will we see active campaigns from the cancer research uk team to the public? After all, “prevention is better than cure” and even more so for the prevention of- (instead of, treatment of) cancer, because with all the funds been raised in the cancer cure department, is it possible that we focused our energies on the wrong plateau, treating cancer cure rather than the prevention in the first place? Well, you don't have to be a rocket scientist to understand that it makes more sense to prevent teenage pregnancies than forming an NP0 for teenage mothers with babies. We need to stop the cancer research uk funding and put some money where our mouth is. Cancer can be beaten but it has to start with common sense and the prevention of cancer makes up a large part of that cancer fighting strategy. http://debunkcancer.blogspot.com